ConductScience.org, home

Library / Trials

Guided Insertion Of Tracheostomy Tubes (GIFT): An Early Feasibility Study

NCT07929662, Not applicable, Not yet recruiting, Manchester University NHS Foundation Trust

Trial 10

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitleGuided Insertion Of Tracheostomy Tubes (GIFT): An Early Feasibility StudyClinicalTrials.gov
NCT numberNCT07929662ClinicalTrials.gov
StatusNot yet recruitingClinicalTrials.gov
PhasesNot applicableClinicalTrials.gov
Enrollment30 participants, estimatedClinicalTrials.gov
Lead sponsorManchester University NHS Foundation TrustClinicalTrials.gov
ConditionsTracheostomyClinicalTrials.gov
InterventionsGIFTClinicalTrials.gov
First posted2026-11-10ClinicalTrials.gov
Last updated2026-11-10ClinicalTrials.gov

Registered outcomes 7

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
PrimarySafety Feasibility: Device deficiency that leads to a Serious Adverse EventPerioperative/Periprocedural
Device deficiencies that lead to Serious Adverse Events (SAE). SAE is defined in the protocol by Medical Device Regulations. SAE's are defined as any untoward medical occurrence that: * Results in death * Is life-threatening * Requires In-patient hospitalization or prolongation of existing hospitalization\*\* * Results in persistent or significant disability/incapacity * Is a congenital anomaly/birth defect * Is otherwise considered medically significant by the investigator
ClinicalTrials.gov
PrimaryUsability Feasibility: System Usability ScalePerioperative/Periprocedural
System Usability Scale (SUS Questionnaire) SUS Questionnaire is completed by PDT Operator, Airway Operator and Bedside Nurse after each GIFT-PDT procedure. * Perceived ease of use * Perceived complexity * Learnability * Overall system usability Total SUS scores (calculated). Score is out of 100 where 0 is the least usable and 100 is the most usable. Using the validated SUS sclae allows the investigators to compare with published typical scores for new technology in general, and for new technologies introduced into critical care.
ClinicalTrials.gov
PrimaryPerformance Feasibility: Procedural successPerioperative/Periprocedural
Procedural success is defined as use of the GIFT System to guide insertion of the PDT needle into the trachea where distance from target is within the clinically acceptable range. Clinically acceptable range for GIFT-PDT is a distance from target ≤9.4mm. Distance from target (mm) is the distance between the optimal insertion point and the actual insertion point of the PDT needle. The lower the distance from target, the better (more accurate).
ClinicalTrials.gov
SecondaryExploratory feasibility: Total PDT TimePerioperative/PeriproceduralTotal PDT time (time from procedure start (the team brief or "time out") to removal of the sterile drape that signifies the end of the PDT procedure).ClinicalTrials.gov
SecondaryExploratory feasibility: Needle Puncture TimePerioperative/PeriproceduralNeedle puncture time (time from first insertion of the needle to operator-declared successful needle insertion)ClinicalTrials.gov
SecondaryExploratory feasibility: Needle InsertionsPerioperative/PeriproceduralNumber of needle insertions (one insertion is defined as the needle entering the skin and then being completely removed).ClinicalTrials.gov
SecondaryExploratory feasibility: Depth to tracheal targetPerioperative/PeriproceduralDepth to tracheal target (measured depth from skin to tracheal target sensor)ClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource

Participant flow 0

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource

Adverse event totals 0

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource

Papers 1

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
41743324BACKGROUNDPubMed

Grants 0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal yearsSource

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource

Source 5

FieldValueSource
Releasetrials-2026-11-12-0.4.0ClinicalTrials.gov
Release manifest SHA-2560f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov
NIH clinical studies file2026-11-13ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)